Skip to Content

  • Search

View Additional Section Content

Long-term, prospective, multinational, parallel-cohort study monitoring safety in patients with MS newly started with fingolimod once daily or treated with another approved disease-modifying therapy

For more information on this trial, click the link below.

https://clinicaltrials.gov/ct2/show/NCT01442194?term=fingolimod+once+daily+or+treated&rank=1

Clinical Trial Categories

  • Multiple Sclerosis
Contact
Jennifer McGowan at 215-327-0161

Location

  • Abington Neurological Associates, Ltd

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a
Test

215-481-EXAM

Clinical Trials Details